|
FUT11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.505000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.614600E-01 |
| Normal-vs-Stage2 |
5.981600E-01 |
| Normal-vs-Stage3 |
5.193200E-01 |
| Normal-vs-Stage4 |
7.455800E-01 |
| Stage1-vs-Stage2 |
4.622800E-01 |
| Stage1-vs-Stage3 |
3.151200E-01 |
| Stage1-vs-Stage4 |
6.233400E-01 |
| Stage2-vs-Stage3 |
9.888800E-01 |
| Stage2-vs-Stage4 |
8.323800E-01 |
| Stage3-vs-Stage4 |
8.012800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.434200E-01 |
| Normal-vs-AfricanAmerican |
3.504000E-01 |
| Normal-vs-Asian |
7.153200E-01 |
| Caucasian-vs-AfricanAmerican |
3.305000E-01 |
| Caucasian-vs-Asian |
5.736600E-01 |
| AfricanAmerican-vs-Asian |
2.429600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.226200E-01 |
| Normal-vs-Female |
7.969400E-01 |
| Male-vs-Female |
3.876300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.638600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.828000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.859400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.874400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.323700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.786600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.183200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.521000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.870200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.501600E-02 |
| Classical-VS-Follicular |
1.01729999979483E-08 |
| Classical-VS-Other |
7.405900E-02 |
| Classical-VS-Normal |
2.000200E-01 |
| Tall-VS-Follicular |
3.807900E-02 |
| Tall-VS-Other |
1.989240E-01 |
| Tall-VS-Normal |
5.730200E-01 |
| Follicular-VS-Other |
8.806000E-01 |
| Follicular-VS-Normal |
1.783170E-03 |
| Other-VS-Normal |
1.036030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.196600E-01 |
| Normal-vs-N1 |
7.269400E-01 |
| N0-vs-N1 |
6.704400E-01 |
|
|
